The Efficacy of Using Pentoxifylline in Patients Undergoing Breast Cancer Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

October 30, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Post-Surgical ComplicationBreast Cancer Surgery
Interventions
DRUG

Pentoxifylline

"Two 400 mg extended-release pentoxifylline oral tablets are administered 2 hours before surgery, then one tablet three times per day after surgery, and continued for four weeks after the surgery.~Standard of care for pain management, including paracetamol 1g IV every 8 hours and Ketorolac 30 mg IV every 12 hours."

DRUG

paracetamol +ketorolac

"Patients receive the usual treatment only:~paracetamol 1g IV every 8 hours and Ketorolac 30 mg IV every 12 hours"

Trial Locations (1)

Unknown

Oncology center of Mansoura University, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT06087237 - The Efficacy of Using Pentoxifylline in Patients Undergoing Breast Cancer Surgery | Biotech Hunter | Biotech Hunter